Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Skin problems are very common in people with end-stage kidney disease.

Ice-skating athletes often have skin problems due to cold, infections, and inflammation, needing careful treatment and prevention.

Genetics play a role in acne, but how exactly they contribute is not fully understood.

Asian immigrant mothers in Leicestershire need better obstetric care to reduce higher perinatal mortality risks.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Older adults have a wide range of skin conditions, with dry skin being very common and many also experiencing skin growths, itching, and infections.

Glycerin in hand cream can cause allergic skin reactions.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

Microemulsions and nanoemulsions can effectively deliver drugs through the skin, but more research is needed to understand their differences and mechanisms.

Levodopa for Parkinson's disease might be linked to skin issues like melanoma, but it's unclear if the drug or the disease causes them.

Early treatment of acne is important to prevent scarring and improve appearance, using medications that can have side effects.

Careful management of blood thinners is crucial for lupus patients with APS.

The document concludes that modern photo stories help represent and challenge how breast cancer affects women's identities and societal norms.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Retinoids and narrowband UVB phototherapy are effective for treating psoriasis and can reduce treatment time when used together.

Dermoscopy helps diagnose unusual skin lesions like osteonevus of Nanta and can prevent misdiagnosis of serious conditions.

Dermatologists diagnose and manage melanoma more effectively than general practitioners.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Living with lupus as both a patient and doctor improved understanding and care for others.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

A fungus ball in the lung can cause coughing up blood in SLE patients.